J Laryngol Otol. 2017 Dec;131(12):1131-1141. doi: 10.1017/S002221511700202X.
Epistaxis is a common condition that can be associated with significant morbidity, and it places a considerable burden on our healthcare system. This national audit of management sought to assess current practice against newly created consensus recommendations and to expand our current evidence base.
The management of epistaxis patients who met the inclusion criteria, at 113 registered sites across the UK, was compared with audit standards during a 30-day window. Data were further utilised for explorative analysis.
Data for 1826 cases were uploaded to the database, representing 94 per cent of all cases that met the inclusion criteria at participating sites. Sixty-two per cent of patients were successfully treated by ENT clinicians within 24 hours. The 30-day recurrent presentation rate across the dataset was 13.9 per cent. Significant event analysis revealed an all-cause 30-day mortality rate of 3.4 per cent.
Audit findings demonstrate a varying alignment with consensus guidance, with explorative analysis countering some previously well-established tenets of management.
鼻出血是一种常见病症，可能伴有严重的发病率，给我们的医疗系统带来相当大的负担。这项全国性的管理审计旨在对照新制定的共识性建议评估当前的治疗方法，并扩充我们现有的证据基础。
在30天的时间范围内，将英国113个注册地点符合纳入标准的鼻出血患者的治疗情况与审计标准进行比较。数据进一步用于探索性分析。
1826例病例的数据被上传至数据库，占参与地点符合纳入标准的所有病例的94%。62%的患者在24小时内由耳鼻喉科临床医生成功治疗。整个数据集的30天复发率为13.9%。重大事件分析显示全因30天死亡率为3.4%。
审计结果表明与共识性指导的一致性存在差异，探索性分析对一些先前确立的治疗原则提出了挑战。
